Overview

Phase II Dose Titration Study in Patients With Neuropathic Pain

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of various increasing doses of Ralfinamide in patients with neuropathic pain.
Phase:
Phase 2
Details
Lead Sponsor:
Newron
Newron Pharmaceuticals SPA